Clinician-Scientist
Division of Infectious Diseases, Department of Medicine, St. Michael's Hospital
Toronto, ON, Canada
Darrell H. S. Tan is an infectious diseases physician and Clinician-Scientist at St. Michael’s Hospital, where he leads the Options Collaboratory in HIV/STI Treatment and Prevention Science (www.optionslab.ca). He is also an Associate Professor in the Department of Medicine at the University of Toronto, with cross-appointments at the Institute of Health Policy, Management and Evaluation and in the Institute of Medical Science. His research focuses on clinical trials and implementation science in the areas of HIV prevention and treatment, sexually transmitted infections (STIs), and mpox. Dr. Tan holds a Tier 2 Canada Research Chair in HIV Prevention and STIs, is Co-Lead of the HIV Prevention Core of the CIHR Canadian HIV Trials Network and is a member of the Governing Council of the International AIDS Society.
Disclosure(s): Gilead Sciences: Grant/Research Support (Terminated); Glaxo Smith Kline: Grant/Research Support (Ongoing)
Thursday, October 17, 2024
3:15 PM – 4:30 PM US PT
227 - Should we invest in post-exposure prophylaxis (PEP) as a tool to end the HIV epidemic? Pro
Thursday, October 17, 2024
3:51 PM – 4:09 PM US PT